<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE FINANCIAL STATEMENTS FOR REPLIGEN CORPORATION AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <CIK> 0000730272 <NAME> REPLIGEN CORPORATION <MULTIPLIER> 1 <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> MAR-31-1996 <PERIOD-START> APR-01-1995 <PERIOD-END> JUN-30-1995 <CASH> 7,588,041 <SECURITIES> 4,012,263 <RECEIVABLES> 2,187,739 <ALLOWANCES> (300,000) <INVENTORY> 1,520,943 <CURRENT-ASSETS> 16,020,923 <PP&E> 20,312,117 <DEPRECIATION> 15,738,139 <TOTAL-ASSETS> 22,103,079 <CURRENT-LIABILITIES> 8,944,920 <BONDS> 0 <COMMON> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 153,589 <OTHER-SE> 13,004,570 <TOTAL-LIABILITY-AND-EQUITY> 22,103,079 <SALES> 392,091 <TOTAL-REVENUES> 2,836,316 <CGS> 290,147 <TOTAL-COSTS> 4,068,182 <OTHER-EXPENSES> 1,406,754 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (2,638,620) <INCOME-TAX> 0 <INCOME-CONTINUING> (2,638,620) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (2,638,620) <EPS-PRIMARY> (0.17) <EPS-DILUTED> (0.17)